LEP and obesity disorder: Moreover, leptin can affect the expression of miRNAs in an endocrine manner (e.g., miR-21, miR-27a/b and miR-122) in the liver and, in this way, contribute to obesity-associated liver steatosis (NAFLD) and inflammation (NASH) (reviewed in [124]).